Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Nearly one in 10 Britons use or want weight-loss medication
A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
Simple blood test could identify the most effective obesity drug
A simple fasting blood test measuring two key incretin hormones could help match patients with severe obesity to…
GLP-1 medications show mixed effects on body contouring outcomes
For patients undergoing body contouring surgery to remove excess abdominal skin after massive weight loss, use of GLP-1 weight-loss medications may have mixed effects…
Short-duration psychedelic therapy shows promise for major depression treatment
A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation…
Users prioritize weight loss despite side effects
An examination of user reviews finds that people continue off-label Ozempic when it delivers results, even if side…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
Searches for “Ozempic face” surge as people look for filler-based solutions
New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
Diabetes remission possible with GLP-1 drugs, Italian study confirms
Real-world data from over 14,000 Italian adults reveal that GLP-1 receptor agonists can induce remission in type 2…
New insight into TRPM3 heat sensor reveals how the body detects temperature
The ability to sense heat protects the body from burns and injury. But how the body actually feels…
Are GLP-1 drugs safe for women planning pregnancy?
New national data reveal a sharp rise in GLP-1 prescriptions for young women, but low contraception use leaves…
GIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
A new study uncovers how GIPR signaling in brain cells helps GLP-1 weight-loss drugs bypass the blood-brain barrier…